National Psoriasis Foundation President and CEO joins board of directors of the National Health Council

Last December, the National Health Council (NHC), an organization of 100 national health-related charities and businesses dedicated to people with chronic illnesses, named Randy Beranek, president and CEO of the National Psoriasis Foundation, to its board of directors for 2011.

Beranek joins six other executives from various health sectors as board members. The membership of the NHC also appointed five new officers.

As a board member, Beranek will represent the psoriasis community and help the NHC achieve its strategic priorities.

The National Health Council brings together all segments of the health care community to provide a unified voice for the more than 133 million people with chronic diseases and disabilities and their family caregivers. Its core membership includes approximately 50 of the nation's leading patient advocacy organizations, which control its governance. Other members include professional and membership associations; nonprofit organizations with an interest in health; and major pharmaceutical, medical device, health insurance and biotechnology companies.

Learn more about the National Health Council »


About the National Psoriasis Foundation

Serving its community through more than 50 years of patient support, advocacy, research funding, and education, the National Psoriasis Foundation (NPF) is the world’s leading nonprofit fighting for individuals with psoriasis and psoriatic arthritis. The NPF mission is to drive efforts to cure psoriatic disease and dramatically improve the lives of more than 8 million Americans affected by this chronic immune-mediated disease. As part of that effort, NPF created its Patient Navigation Center to offer personalized assistance to everyone with psoriasis or psoriatic arthritis. To date, NPF has funded more than $17 million in research grants and fellowships that help drive discoveries that may lead to more and better treatments and ultimately a cure. Learn more at www.psoriasis.org.